Cytek narrows 2025 revenue outlook to $196M-$205M amid recurring revenue growth and new product launches
Source: SeekingAlpha
2025-08-07 04:26:40 ET
More on Cytek Biosciences
- Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript
- Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Cytek Biosciences
- Historical earnings data for Cytek Biosciences
- Financial information for Cytek Biosciences
Read the full article on Seeking Alpha
For further details see:
Cytek narrows 2025 revenue outlook to $196M-$205M amid recurring revenue growth and new product launches
Cytek Biosciences Inc.
NASDAQ: CTKB
CTKB Trading
2.66% G/L:
$4.435 Last:
410,952 Volume:
$4.29 Open:
CTKB Latest News
March 09, 2026 05:00:00 pm
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
February 26, 2026 04:05:00 pm
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
CTKB Stock Data
$553,654,714
114,656,393
9.13%
48
N/A
Biotechnology & Life Sciences
Healthcare
US
Fremont
